A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...
In a week set aside to stress good cybersecurity practices, officials in three states with strong consumer privacy laws are urging consumers to take advant ...
Learn more about whether ESCO Technologies Inc. or Federal Signal Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.